News
-
ACLA writes CMS Administrator Verma, urging delay and fix to PAMA
... -
ACLA Letter on Medicare Program to Ways and Means Health Subcommittee
... -
ACLA Praises Gottlieb Confirmation as FDA Commissioner
Clinical Laboratory Community Commends New Commissioner For Both His Medical and Government Experience, Support for Scientific Innovation (Washington, D.C.) – The Senate confirmation today of Scott Gottlieb, M.D. as Commissioner of the Food and Drug Administration (FDA), drew praise from the American Clinical Laboratory Association (ACLA), the nation’s leading organization representing clinical laboratories. Commending Dr. Gottlieb for his experience in both the clinical andContinue Reading »... -
ACLA Comments on Bucshon-DeGette Discussion Draft Impacting the Regulation of Clinical Laboratory Diagnostics
(Washington, D.C.) – Today, the American Clinical Laboratory Association (ACLA) submitted comments in response to a discussion draft, the Diagnostic Accuracy and Innovation Act (DAIA), recently released by Representatives Larry Bucshon, M.D. (R-IN) and Diana DeGette (D-CO). ACLA’s comments reiterate the association’s continued support of comprehensive statutory reform to create a distinct framework for clinical laboratory diagnostics that advances innovation and protects patients, includingContinue Reading »... -
ACLA Comments on March 21, 2017 Discussion Draft of the Diagnostic Accuracy and Innovation Act
... -
ACLA Commends CMS’ Decision to Exercise Enforcement Discretion for Reporting Applicable Information Under PAMA
(Washington, D.C.) – The American Clinical Laboratory Association (ACLA) today lauded the decision by the Centers for Medicare and Medicaid Services (CMS) to exercise enforcement discretion until May 30, 2017 for laboratories reporting private payor pricing data as required by the Protecting Access to Medicare Act (PAMA). “ACLA appreciates the decision by CMS to exercise enforcement discretion until May 30, 2017,” said Julie Khani,Continue Reading »... -
Clinical Laboratories, Laboratory Professionals, Physicians Urge HHS to Delay PAMA Implementation
– Challenges with Data Reporting Requirements, Problems with CMS Reporting Portal Cause Rate Calculation Integrity Concerns; Threaten to Reduce Clinical Lab Infrastructure and Limit Patient Access to Vital Laboratory Test Services – WASHINGTON, D.C. – Ten organizations representing a diverse cross section of the clinical laboratory community – including the American Clinical Laboratory Association – today sent a joint letter to U.S. Department ofContinue Reading »... -
ACLA Letter to HHS Secretary Tom Price About Implementation of the Medicare Clinical Laboratory Fee Schedule (CLFS) Reform as Enacted by Section 216 of the Protecting Access to Medicare Act of 2014 (PAMA).
... -
Leaders in the Clinical Laboratory Community, Congress and the Administration Address Issues Impacting Diagnostics and Patient Care at ACLA’s 22nd Annual Conference
Acclaimed Pulitzer Prize-Winning Author, Oncologist and Cancer Researcher Siddhartha Mukherjee, MD Delivers Keynote Address WASHINGTON, D.C. – Exploring the role of diagnostic innovation in the advancement of precision medicine and the federal policies impacting clinical laboratories was front and center today as congressional, administration, and industry leaders addressed meeting attendees at the American Clinical Laboratory Association’s (ACLA) 22nd annual conference in Washington, D.C. “WeContinue Reading »... -
ACLA Congratulates Newly Confirmed CMS Administrator Seema Verma
(Washington, D.C.) – Following the Senate confirmation this week of Seema Verma as administrator of the Centers for Medicare and Medicaid Services (CMS), the American Clinical Laboratory Association (ACLA), the nation’s leading organization representing clinical laboratories, today extended congratulations to the head of the agency that assumes, among many responsibilities, the setting of Medicare reimbursement rates for health care providers and services. Julie Khani,Continue Reading »...
